Catalpol Protects Against Pulmonary Fibrosis Through Inhibiting TGF-β1/Smad3 and Wnt/β-Catenin Signaling Pathways

• 主要な著者: Fan Yang (著者), Zhen-feng Hou (著者), Hao-yue Zhu (著者), Xiao-xuan Chen (著者), Wan-yang Li (著者), Ren-shuang Cao (著者), Yu-xuan Li (著者), Ru Chen (著者), Wei Zhang (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2021-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by fibroblast proliferation and extracellular matrix remodeling; however, the molecular mechanisms underlying its occurrence and development are not yet fully understood. Despite it having a variety of beneficial pharmacologic...